Skip to contentS
Surgery Partners, Inc.
S
SGRYSurgery Partners, Inc. Q2 2021 · 10-Q
Revenue$543.30M$543.30M+45.0% vs Q2 2020 Net Income-$26.90M-$26.90MN/M vs Q2 2020 EPS Diluted-$0.39-$0.39N/M vs Q2 2020 Operating Income$59,500,000+33.1% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Surgery Partners, Inc. · CIK 1638833 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$11,200,000N/M Margins · derivedOperating margin11.0%−1.0 pt vs Q2 2020
Net margin-5.0%+3.7 pt vs Q2 2020
ended Jun 30, 2021 · filed Aug 4, 2021 · 35 d after period end